Related Experiment Video
Updated: Jan 10, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
An Innovative Insulin Dose Self-Titration Toolkit for Adults Living With Type 2 Diabetes Mellitus
Nadin Abbas1, Heather Lochnan1,2,3, Sandhya Goge4,5
1Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
JMIR Diabetes
|November 28, 2025
Summary
Adults with type 2 diabetes can now self-adjust insulin doses using a new bilingual toolkit. This resource includes personalized plans and educational videos to improve diabetes management.
Area of Science:
- Endocrinology
- Diabetes Management
- Patient Education
Background:
- Type 2 diabetes requires ongoing management, including insulin therapy.
- Insulin dose adjustment can be challenging for patients.
- Effective patient education is crucial for self-management.
Purpose of the Study:
- To develop and evaluate a bilingual toolkit to support insulin dose self-titration.
- To empower adults with type 2 diabetes in managing their insulin therapy.
- To improve adherence and outcomes through patient-centered tools.
Main Methods:
- Development of a bilingual toolkit including personalized action plans and educational videos.
- Targeted at adults with type 2 diabetes on insulin therapy.
- Focus on self-titration of insulin doses.
Main Results:
- The toolkit provides a structured approach to insulin self-management.
- Bilingual resources cater to diverse patient populations.
- Educational videos enhance understanding of insulin titration.
Conclusions:
- The developed toolkit is an innovative approach to support insulin self-titration.
- This resource has the potential to improve diabetes self-management in adults with type 2 diabetes.
- Further research should assess the impact on clinical outcomes.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
658
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
658
01:27Insulin Formulations: Types and Delivery
622
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
622
01:24Dosage Regimen: Individualization
154
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
154
01:15Diabetes: Management and Pharmacotherapy
848
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
848
01:22Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
01:22Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K